FMR LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.

Quarter-by-quarter ownership
FMR LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$231,682,118
+12.2%
1,911,253
+6.0%
0.02%
+17.6%
Q2 2023$206,574,348
-71.7%
1,803,828
-65.9%
0.02%
-48.5%
Q1 2023$729,025,890
+107.1%
5,289,312
+94.7%
0.03%
-5.7%
Q4 2022$351,948,496
+24.9%
2,716,071
+6.5%
0.04%
+20.7%
Q3 2022$281,857,000
+125.6%
2,549,828
+53.0%
0.03%
+141.7%
Q2 2022$124,946,000
+3.2%
1,666,836
+7.5%
0.01%
+20.0%
Q1 2022$121,081,000
-53.6%
1,549,936
-46.5%
0.01%
-47.4%
Q4 2021$260,908,000
-32.0%
2,897,373
-30.2%
0.02%
-36.7%
Q3 2021$383,926,000
+11.6%
4,151,448
-6.2%
0.03%
+11.1%
Q2 2021$344,171,000
+4.2%
4,427,198
-0.1%
0.03%
-3.6%
Q1 2021$330,142,000
-67.9%
4,429,653
-26.6%
0.03%
-69.6%
Q4 2020$1,028,803,000
+15.5%
6,034,389
-4.9%
0.09%
+2.2%
Q3 2020$890,846,000
-29.0%
6,343,696
-18.9%
0.09%
-34.8%
Q2 2020$1,254,637,000
+73.0%
7,824,854
+5.5%
0.14%
+38.0%
Q1 2020$725,315,000
-31.3%
7,414,794
-9.3%
0.10%
-13.8%
Q4 2019$1,055,192,000
+73.8%
8,177,245
+1.4%
0.12%
+58.9%
Q3 2019$607,238,000
-56.6%
8,062,097
-12.4%
0.07%
-55.2%
Q2 2019$1,397,662,000
+7.0%
9,198,171
-16.0%
0.16%
+4.5%
Q1 2019$1,305,917,000
+13.3%
10,956,596
+3.7%
0.16%
-1.3%
Q4 2018$1,152,977,000
-27.8%
10,565,177
+6.9%
0.16%
-12.2%
Q3 2018$1,596,887,000
+23.9%
9,887,230
+1.4%
0.18%
+21.6%
Q2 2018$1,288,739,000
+79.9%
9,749,879
+0.9%
0.15%
+74.1%
Q1 2018$716,260,000
+134.7%
9,667,426
+76.2%
0.08%
+136.1%
Q4 2017$305,241,000
+233.4%
5,486,017
+171.8%
0.04%
+227.3%
Q3 2017$91,560,000
+149.6%
2,018,532
+85.5%
0.01%
+120.0%
Q2 2017$36,676,000
+10.4%
1,087,997
-3.0%
0.01%
+25.0%
Q1 2017$33,211,000
+1.2%
1,121,997
-6.3%
0.00%0.0%
Q4 2016$32,828,000
-65.2%
1,196,797
-22.0%
0.00%
-69.2%
Q3 2016$94,227,000
+174.1%
1,534,397
-14.9%
0.01%
+160.0%
Q2 2016$34,381,000
-2.3%
1,802,8970.0%0.01%0.0%
Q1 2016$35,193,000
-61.5%
1,802,897
-23.9%
0.01%
-58.3%
Q4 2015$91,373,000
+37.1%
2,368,397
+14.1%
0.01%
+33.3%
Q3 2015$66,667,000
+5.5%
2,076,2120.0%0.01%
+12.5%
Q2 2015$63,179,000
+278.3%
2,076,212
+65.1%
0.01%
+300.0%
Q1 2015$16,699,000
-8.2%
1,257,4330.0%0.00%0.0%
Q4 2014$18,195,000
-31.4%
1,257,4330.0%0.00%
-50.0%
Q3 2014$26,532,000
-29.2%
1,257,4330.0%0.00%
-20.0%
Q2 2014$37,459,000
+44.3%
1,257,433
+16.4%
0.01%
+25.0%
Q1 2014$25,951,000
+18.0%
1,079,9330.0%0.00%
+33.3%
Q4 2013$21,998,000
-64.2%
1,079,933
-16.9%
0.00%
-66.7%
Q3 2013$61,406,000
+88.3%
1,300,162
+51.7%
0.01%
+80.0%
Q2 2013$32,619,000857,2620.01%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 112,689$14,541,00014.93%
Casdin Capital, LLC 670,000$86,457,0007.95%
Logos Global Management LP 226,002$29,163,0007.19%
Avoro Capital Advisors LLC 1,760,000$227,110,0006.67%
Camber Capital Management LP 600,000$77,424,0003.94%
STANSBERRY ASSET MANAGEMENT, LLC 71,133$9,179,0003.74%
Eventide Asset Management 996,000$128,524,0003.62%
CADIAN CAPITAL MANAGEMENT, LP 550,000$70,972,0003.14%
RTW INVESTMENTS, LP 605,762$78,168,0002.95%
Consonance Capital Management LP 356,145$45,957,0002.80%
View complete list of SAREPTA THERAPEUTICS INC shareholders